Higher Risks for Artificially Conceived Infants
By Miriam Zoll, <i>Biopolitical Times</i> guest contributor
| 03. 12. 2014
Data about the risks involved in high-tech assisted reproduction have until recently been scarce. The industry naturally touts success rates and downplays failures, and the Centers for Disease Control and Prevention (CDC) has largely been restricted to sharing only self-reported data from clinics with the public. But this is changing—and families intending to use these technologies should be aware of the full implications of the statistics that are available.
Last month, for instance, the Society for Assisted Reproductive Technologies announced that a record number of babies were born – 61,740 – as a result of the 165,172 in vitro fertilization (IVF) cycles performed at 379 of its member clinics in 2012.1
On the surface, this announcement may be perceived as an endorsement for the success of reproductive medical services that have, undoubtedly, helped many couples over the last 35 years to bear the children they might otherwise not have been able to. As we celebrate the births of these babies, however, it is also important to recognize that the vast majority of IVF cycles continue to fail, and that...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...